707
Views
21
CrossRef citations to date
0
Altmetric
Review Article

Medically induced hypertension, hypervolaemia and haemodilution for the treatment and prophylaxis of vasospasm following aneurysmal subarachnoid haemorrhage: systematic review

ORCID Icon, &
Pages 157-164 | Received 23 May 2017, Accepted 08 Jan 2018, Published online: 17 Jan 2018

References

  • de Rooij NK, Linn FHH, van der Plas JA, Algra A, Rinkel GJE. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007;78:1365–72.
  • Kassell NF, Torner JC, Fau - Haley EC, et al. The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neurosurg 1990;73:18–36.
  • Locksley HB. Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. J Neurosurg 1966;25:321–68.
  • Lantigua H, Ortega-Gutierrez S, Schmidt JM, et al. Subarachnoid hemorrhage: who dies, and why? Crit Care 2015;19:309.
  • Velly LJ, Bilotta F, Fabregas N, Soehle M, Bruder NJ, Nathanson MH. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage a survey of European practice. Eur J Anaesthesiol. Vol 32. United Kingdom: Lippincott Williams and Wilkins 2015;32:168–76.
  • Dorhout MS, Rinkel GJE, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Coch Database Syst Rev 2007;CD000277.
  • Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992;77:848–52.
  • Lopes D, Mangubat E, Fau - Keigher K, Keigher K, Fau - Cogan C, Cogan C. Should we use stents in subarachnoid hemorrhage? J Neurosurg Sci 2011;55:35–8.
  • Rosenwasser RH, Fau - Delgado TE, Delgado TE, et al. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery 1983;12:658–61.
  • Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke 2012;43:1711–37.
  • Meyer R, Deem S, Yanez ND, Souter M, Lam A, Treggiari MM. Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage. Neurocrit Care 2011;14:24–36.
  • Hyodo A, Heros RC, Fau - Tu YK, et al. Acute effects of isovolemic hemodilution with crystalloids in a canine model of focal cerebral ischemia. Stroke 1989;20:534–40.
  • Molyneux A, Kerr R, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–74.
  • Mutoh T, Kazumata K, Ajiki M, Ushikoshi S, Terasaka S. Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage. Stroke 2007;38:3218–24.
  • Reynolds MR, Buckley RT, Indrakanti SS, et al. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms. J Neurosurg 2015;123:862–71.
  • Dhar R, Scalfani MT, Zazulia AR, et al. Comparison of induced hypertension, fluid bolus, and blood transfusion to augment cerebral oxygen delivery after subarachnoid hemorrhage. J Neurosurg 2012;116:648–56.
  • Oertel M, Boscardin WJ, Fau - Obrist WD, et al. Posttraumatic vasospasm: the epidemiology, severity, and time course of an underestimated phenomenon: a prospective study performed in 299 patients. J Neurosurg 2005;103:812–24.
  • Dabus G, Nogueira RG. Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature. Intervent Neurol 2013;2:30–51.
  • Lennihan L, Mayer SA, Fink ME, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000;31:383–91.
  • Egge A, Waterloo K, Sjøholm H, et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001;49:593–605.
  • Gathier CS, Dankbaar JW, Van Der Jagt M, et al. effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke 2015;46:3277–81.
  • Gathier CS, van den Bergh WM, Slooter AJ. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage. Int J Stroke 2014;9:375–80.
  • Rondeau N, Cinotti R, Rozec B, et al. Dobutamine-induced high cardiac index did not prevent vasospasm in subarachnoid hemorrhage patients: a randomized controlled pilot study. Neurocrit Care 2012;17:183–90.
  • Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044–54.
  • Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81–4.
  • Cochrane handbook for systematic reviews of interventions. Vol 5. Chichester: Wiley-Blackwell; 2008.
  • Tagami T, Kuwamoto K, Watanabe A, et al. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2014;21:462–9.
  • Togashi K, Joffe AM, Sekhar L, et al. Randomized pilot trial of intensive management of blood pressure or volume expansion in subarachnoid hemorrhage (IMPROVES). Neurosurgery 2015;76:125–134. discussion 134–125.
  • Vermeij FH, Hasan D, Bijvoet HW, Avezaat CJ. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage. Stroke 1998;29:924–30.
  • Yano K, Kuroda T, Tanabe Y, Yamada H. Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy. Acta Neurochir (Wien) 1993;125:159.
  • Frontera JA, Fernandez A, Schmidt JM, et al. Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage. Neurosurgery 2010;66:35–41.
  • Kissoon NR, Mandrekar JN, Fugate JE, Lanzino G, Wijdicks EF, Rabinstein AA. Positive fluid balance is associated with poor outcomes in subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2015;24:2245–51.
  • Roy B, McCullough LD, Dhar R, Grady J, Wang YB, Brown RJ. Comparison of initial vasopressors used for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2017;43:266–71.
  • Murphy A, de Oliveira Manoel AL, Macdonald RL, et al. Changes in cerebral perfusion with induced hypertension in aneurysmal subarachnoid hemorrhage: a pilot and feasibility study. Neurocrit Care 2017;27:3–10.
  • Ibrahim GM, Macdonald RL. The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. Neurocrit Care 2013;19:140–9.
  • Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480–4.
  • Frontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?. Stroke 2009;40:1963–8.
  • Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010;41:2391–5.
  • Veldeman M, Hollig A, Clusmann H, Stevanovic A, Rossaint R, Coburn M. Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review. Br J Anaesth 2016;117:17–40.
  • Latorre JG, Lodi Y, El-Zammar Z, Devasenapathy A. Is asymptomatic vasospasm associated with poor outcome in subarachnoid hemorrhage? Neurohospitalist 2011;1:165–71.
  • Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 2000;68:337–41.
  • Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma: a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg 2016;127:732-739.
  • Kolias AG, Cowie CJ, Tarnaris A, Hutchinson PJ, Brennan PM. Proposal for a British neurosurgical trainee research collaborative. Br J Neurosurg 2012;26:434–5.
  • Kolias AG, Scotton WJ, Belli A, et al. Surgical management of acute subdural haematomas: current practice patterns in the United Kingdom and the Republic of Ireland. Br J Neurosurg 2013;27:330–3.
  • Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991;337:867–72.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.